piracetam has been researched along with Kidney Failure in 6 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 17-year-old girl who had started on levetiracetam because of new onset partial complex seizures developed acute renal failure and biopsy-confirmed interstitial nephritis 10 days after starting the drug." | 7.75 | Levetiracetam induced interstitial nephritis and renal failure. ( Hurwitz, KA; Ingulli, EG; Krous, HF, 2009) |
| "Levetiracetam was started with a good response." | 5.40 | Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome. ( López-González, FJ; Novoa, D; Pardo, J; Pintos, E; Rodríguez-Osorio, X, 2014) |
| " Levetiracetam is one of the new generation of AEDs licensed as an add-on therapy for the treatment of patients with partial-onset seizures." | 4.82 | Safety profile of levetiracetam. ( Arroyo, S; Crawford, P, 2003) |
| "A 17-year-old girl who had started on levetiracetam because of new onset partial complex seizures developed acute renal failure and biopsy-confirmed interstitial nephritis 10 days after starting the drug." | 3.75 | Levetiracetam induced interstitial nephritis and renal failure. ( Hurwitz, KA; Ingulli, EG; Krous, HF, 2009) |
| " Noncompartmental pharmacokinetic parameters were calculated and steady-state profiles were simulated using the superposition method." | 2.79 | Levetiracetam pharmacokinetics in Japanese subjects with renal impairment. ( Kumagai, Y; Stockis, A; Toublanc, N; Yamamoto, J, 2014) |
| " The peak concentration at steady state was 32." | 1.43 | Levetiracetam Pharmacokinetics During Continuous Venovenous Hemofiltration and Acute Liver Dysfunction. ( Frazee, EN; Kashani, KB; Nei, SD; New, AM; Rabinstein, AA, 2016) |
| "Levetiracetam was started with a good response." | 1.40 | Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome. ( López-González, FJ; Novoa, D; Pardo, J; Pintos, E; Rodríguez-Osorio, X, 2014) |
| "Levetiracetam is a broad spectrum anti-epileptic drug with renal elimination and no hepatic metabolism." | 1.35 | Levetiracetam accumulation in renal failure causing myoclonic encephalopathy with triphasic waves. ( Iwanowski, P; Jallon, P; Landis, T; Vulliemoz, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez-Osorio, X | 1 |
| Pardo, J | 1 |
| López-González, FJ | 1 |
| Novoa, D | 1 |
| Pintos, E | 1 |
| Yamamoto, J | 1 |
| Toublanc, N | 1 |
| Kumagai, Y | 1 |
| Stockis, A | 1 |
| New, AM | 1 |
| Nei, SD | 1 |
| Kashani, KB | 1 |
| Rabinstein, AA | 1 |
| Frazee, EN | 1 |
| Vulliemoz, S | 1 |
| Iwanowski, P | 1 |
| Landis, T | 1 |
| Jallon, P | 1 |
| Hurwitz, KA | 1 |
| Ingulli, EG | 1 |
| Krous, HF | 1 |
| Arroyo, S | 1 |
| Crawford, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Study of Pharmacokinetics of Levetiracetam in Patients Undergoing Intermittent Hemodialysis[NCT04511676] | 12 participants (Actual) | Observational | 2018-11-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for piracetam and Kidney Failure
| Article | Year |
|---|---|
Safety profile of levetiracetam.
Topics: Age Factors; Anticonvulsants; Drug Interactions; Epilepsy; Humans; Levetiracetam; Persons with Menta | 2003 |
1 trial available for piracetam and Kidney Failure
| Article | Year |
|---|---|
Levetiracetam pharmacokinetics in Japanese subjects with renal impairment.
Topics: Adult; Aged; Animals; Case-Control Studies; Dose-Response Relationship, Drug; Humans; Japan; Kidney | 2014 |
4 other studies available for piracetam and Kidney Failure
| Article | Year |
|---|---|
Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome.
Topics: Anticonvulsants; Drug Hypersensitivity Syndrome; Epilepsy; Humans; Levetiracetam; Liver Failure; Mal | 2014 |
Levetiracetam Pharmacokinetics During Continuous Venovenous Hemofiltration and Acute Liver Dysfunction.
Topics: Anticonvulsants; Hemofiltration; Humans; Levetiracetam; Liver Failure, Acute; Male; Middle Aged; Pir | 2016 |
Levetiracetam accumulation in renal failure causing myoclonic encephalopathy with triphasic waves.
Topics: Aged, 80 and over; Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; L | 2009 |
Levetiracetam induced interstitial nephritis and renal failure.
Topics: Adolescent; Adrenal Cortex Hormones; Anticonvulsants; Contraindications; Female; Humans; Kidney; Lev | 2009 |